Sold by the manufacturers under the brand name Taxotere, Docetaxel Anhydrous is primarily a chemotherapy medication used while treating several kinds of cancer. These include non-small-cell lung cancer, prostate cancer, stomach cancer, neck, and head cancer, and breast cancer. It can be used either in conjunction with other chemotherapy medicines or can be used as it is. It is slowly injected into a vein.

Docetaxel interacts with filament growth's natural function. In contrast to medications like colchicine, which promotes the depolymerization of microtubules in vivo, docetaxel inhibits their action by hyper-stabilizing their architecture. The cell's capacity to employ its microtubule flexibly is destroyed as a result of this. Docetaxel interacts with tubulin's subsidiary in particular. Tubulin is the "basic foundation" of the cytoskeleton, and docetaxel binds to these construction blocks, locking them in position. The docetaxel compound that results is unable to disassemble. Because the shrinking and elongation of the cytoskeleton (known as dynamic instability) are required for their function as a cell's transport route, this harms cell activity.

Docetaxel is used in the treatment of different kinds of cancers. There is sufficient clinical evidence to prove that this drug has cytotoxic activity against melanoma and other forms of cancer. It improves the overall quality of life and also life expectancy in the case of hormone-refractory prostate cancer. Although the optimal dose scheduling of this drug is not confirmed, several studies have established that there is a significant mortality benefit after a week of administration schedule.

The manufacturers market Docetaxel Anhydrous under the name Taxotere. The leading Docetaxel Anhydrous manufacturer in the world is Sanofi-Aventis. The other players in the industry are Zytax by Zydus and Sun Pharma Global. The annual sales of this drug in the year 2010 were €2.122 billion. Rhone-Poulenc Rorer (now known as Sanofi Aventis) developed Taxotere following the discoveries of Pierre Potier. He was working on improving the production of Taxol. The company invested in the research and made a breakthrough that is giving hope to many cancer patients in the world.

If you are keen on becoming a Docetaxel distributor, then you should consider connecting with the leading manufacturers of this drug on a reliable platform. Pipelinepharma is an online global pharma marketplace that lets you connect with leading Docetaxel Anhydrous manufacturers. The platform equips you with tools to level your game and negotiate the terms at your convenience. You have a lot of tools at your disposal. Whether you are looking for Docetaxel Anhydrous suppliers or are trying to understand pharma dealings, Pipelinepharma can provide you with all that you are looking for. It is a reliable hub where Docetaxel Anhydrous suppliers and distributors come together to connect with trusted partners.

In the US, the wholesale cost of six cycles of Docetaxel Anhydrous over 18 weeks is $5,262. This cost is for a dose of 75mg/m2 IV. Here the body surface area is taken into consideration. Improvements in the production process can significantly bring down the wholesale cost of this drug over time. Currently, the Docetaxel Anhydrous manufacturers are doing their best to cut down the costs of production. On the Pipelinepharma marketplace, this medicine is for sale and you can easily browse a complete list of Docetaxel Anhydrous offers for B2B purchase, with communication facilitated through the online interface. This allows for a quick and hassle-free sourcing experience, without having to check multiple separate sites for listings.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Docetaxel Anhydrous offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Docetaxel Anhydrous manufacturers and Docetaxel Anhydrous suppliers that you are looking for. These also enable you to check the dossier status of Docetaxel Anhydrous, and the GMP approvals of the different variants of Docetaxel Anhydrous. Also, each manufacturer or supplier product description contains essential information about Docetaxel Anhydrous including clinical data, stability zones, countries where Docetaxel Anhydrous is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Docetaxel Anhydrous offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than the Good Manufacturing Practice approvals that Docetaxel Anhydrous manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Docetaxel Anhydrous manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.